Clinical trials

Janssen Reports Top-Line Phase 3 Results for TREMFYA® (guselkumab) in Adults with Active Psoriatic Arthritis

Retrieved on: 
Friday, June 14, 2019
Health, Biotechnology, Clinical trials, Pharmaceutical, Johnson & Johnson, Monoclonal antibodies, Companies, Organ systems, Health, Cilag, Janssen Pharmaceutica, Guselkumab, Ustekinumab, Psoriasis, Janssen, Pharmaceutical industry

The Janssen Pharmaceutical Companies of Johnson & Johnson maintain exclusive worldwide marketing rights to TREMFYA which is currently approved in the US, Canada and the EU.

Key Points: 
  • The Janssen Pharmaceutical Companies of Johnson & Johnson maintain exclusive worldwide marketing rights to TREMFYA which is currently approved in the US, Canada and the EU.
  • For complete EU prescribing and safety information, please visit: https://www.medicines.org.uk/emc/medicine/34321
    At Janssen, were creating a future where disease is a thing of the past.
  • Janssen-Cilag International NV, the marketing authorisation holder for TREMFYA in the EU, and Janssen Research & Development, LLC, are part of the Janssen Pharmaceutical Companies of Johnson & Johnson.
  • Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double-blind, phase III NAVIGATE trial.

Global Genital Warts Clinical Trial Pipeline Highlights, 2019 - Analysis on Clinical Trial Stages, Drug Mechanism Classes, Short-term Launch Highlights, and Companies - ResearchAndMarkets.com

Retrieved on: 
Friday, June 14, 2019
Health, Clinical trials, Infectious diseases, Pharmaceutical, Health, Infectious causes of cancer, RTT, Medicine, Clinical research, Design of experiments, Clinical trial, Pharmaceutical industry, Genital wart, Ionis Pharmaceuticals, Biotie Therapies

The "Global Genital Warts Clinical Trial Pipeline Highlights, 2019" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Genital Warts Clinical Trial Pipeline Highlights, 2019" report has been added to ResearchAndMarkets.com's offering.
  • This report provides most up-to-date information on key pipeline products in the global Genital Warts market.
  • It covers emerging therapies for Genital Warts in active clinical development stages including early and late stage clinical trials.
  • The report provides Genital Warts pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Global Muscle Spasticity Clinical Trial Pipeline Highlights, 2019 - Analysis on Clinical Trial Stages, Drug Mechanism Classes, Short-term Launch Highlights, and Companies - ResearchAndMarkets.com

Retrieved on: 
Friday, June 14, 2019
Health, Clinical trials, Pharmaceutical, Health, Articles, Design of experiments, Spasticity, Clinical trial, Clinical research, Multiple sclerosis research, Biotie Therapies

The "Global Muscle Spasticity Clinical Trial Pipeline Highlights, 2019" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Muscle Spasticity Clinical Trial Pipeline Highlights, 2019" report has been added to ResearchAndMarkets.com's offering.
  • This report provides most up-to-date information on key pipeline products in the global Muscle Spasticity market.
  • It covers emerging therapies for Muscle Spasticity in active clinical development stages including early and late stage clinical trials.
  • The report provides Muscle Spasticity pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Global Actinic Keratosis Clinical Trial Pipeline Highlights, 2019 - Analysis on Clinical Trial Stages, Drug Mechanism Classes, Short-term Launch Highlights, and Companies - ResearchAndMarkets.com

Retrieved on: 
Friday, June 14, 2019
Health, Clinical trials, Pharmaceutical, Health, Medicine, Clinical research, Design of experiments, Drug discovery, Actinic keratosis, Dermatology, Clinical trial, Keratosis, Actinism

The "Global Actinic Keratosis Clinical Trial Pipeline Highlights, 2019" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Actinic Keratosis Clinical Trial Pipeline Highlights, 2019" report has been added to ResearchAndMarkets.com's offering.
  • This report provides most up-to-date information on key pipeline products in the global Actinic Keratosis market.
  • It covers emerging therapies for Actinic Keratosis in active clinical development stages including early and late stage clinical trials.
  • The report provides Actinic Keratosis pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Global Focal Segmental Glomerulosclerosis Clinical Trial Pipeline Highlights, 2019 - Analysis on Clinical Trial Stages, Drug Mechanism Classes, Short-term Launch Highlights, and Companies - ResearchAndMarkets.com

Retrieved on: 
Friday, June 14, 2019
Health, Clinical trials, Pharmaceutical, Medical specialties, Health, Kidney diseases, Medicine, Glomerulosclerosis, Clinical research, Design of experiments, Drug discovery, Focal segmental glomerulosclerosis, Clinical trial, Fresolimumab

The "Global Focal Segmental Glomerulosclerosis Clinical Trial Pipeline Highlights, 2019" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Focal Segmental Glomerulosclerosis Clinical Trial Pipeline Highlights, 2019" report has been added to ResearchAndMarkets.com's offering.
  • This report provides most up-to-date information on key pipeline products in the global Focal Segmental Glomerulosclerosis market.
  • It covers emerging therapies for Focal Segmental Glomerulosclerosis in active clinical development stages including early and late stage clinical trials.
  • The report provides Focal Segmental Glomerulosclerosis pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Global Hypogonadism Clinical Trial Pipeline Highlights, 2019 - Analysis on Clinical Trial Stages, Drug Mechanism Classes, Short-term Launch Highlights, and Companies - ResearchAndMarkets.com

Retrieved on: 
Friday, June 14, 2019
Health, Clinical trials, Pharmaceutical, Health, Organ systems, Clinical research, Design of experiments, Medicine, Clinical pharmacology, Clinical trial, Pharmaceutical industry, Hypogonadism, Biotie Therapies

The "Global Hypogonadism Clinical Trial Pipeline Highlights, 2019" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Hypogonadism Clinical Trial Pipeline Highlights, 2019" report has been added to ResearchAndMarkets.com's offering.
  • This report provides most up-to-date information on key pipeline products in the global Hypogonadism market.
  • It covers emerging therapies for Hypogonadism in active clinical development stages including early and late stage clinical trials.
  • The report provides Hypogonadism pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Global Pruritus Clinical Trial Pipeline Highlights, 2019 - Analysis on Clinical Trial Stages, Drug Mechanism Classes, Short-term Launch Highlights, and Companies - ResearchAndMarkets.com

Retrieved on: 
Friday, June 14, 2019
Health, Clinical trials, Pharmaceutical, Health, Drug discovery, Clinical research, Design of experiments, Medical research, Medical statistics, Pharmaceutical industry, Clinical trial, Tradipitant, Biotie Therapies

The "Global Pruritus Clinical Trial Pipeline Highlights, 2019" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Pruritus Clinical Trial Pipeline Highlights, 2019" report has been added to ResearchAndMarkets.com's offering.
  • This report provides most up-to-date information on key pipeline products in the global Pruritus market.
  • It covers emerging therapies for Pruritus in active clinical development stages including early and late stage clinical trials.
  • The report provides Pruritus pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Global Celiac Disease Clinical Trial Pipeline Highlights, 2019 - Analysis on Clinical Trial Stages, Drug Mechanism Classes, Short-term Launch Highlights, and Companies - ResearchAndMarkets.com

Retrieved on: 
Friday, June 14, 2019
Health, Clinical trials, Pharmaceutical, Health, Medical specialties, Medicine, Clinical research, Design of experiments, Drug discovery, Autoimmune diseases, RTT, Clinical trial, Coeliac disease, Biotie Therapies, Trevena Inc

The "Global Celiac Disease Clinical Trial Pipeline Highlights, 2019" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Celiac Disease Clinical Trial Pipeline Highlights, 2019" report has been added to ResearchAndMarkets.com's offering.
  • This report provides most up-to-date information on key pipeline products in the global Celiac Disease market.
  • It covers emerging therapies for Celiac Disease in active clinical development stages including early and late stage clinical trials.
  • The report provides Celiac Disease pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

InVivo Therapeutics Announces Adjournment of Annual Meeting

Retrieved on: 
Friday, June 14, 2019
Surgery, Health, Biotechnology, Clinical trials, Research, Science, Majority, Parliamentary procedure, Political terminology, Quorum, Proxy

InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced that its 2019 Annual Meeting of Stockholders, scheduled for June 11, 2019, was convened and adjourned without any business being conducted due to the fact that quorum was not achieved.

Key Points: 
  • InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced that its 2019 Annual Meeting of Stockholders, scheduled for June 11, 2019, was convened and adjourned without any business being conducted due to the fact that quorum was not achieved.
  • The Annual Meeting will be reconvened July 2, 2019 to allow more opportunity for stockholders to vote on all proposals described in the Companys definitive proxy statement filed with the Securities and Exchange Commission (SEC) on April 25, 2019.
  • The record date for the Annual Meeting remains April 22, 2019.
  • Stockholders who hold their shares through a bank or broker can vote through Broadridge using one of the methods below:

Global Epidermolysis Bullosa Clinical Trial Pipeline Highlights, 2019 - Analysis on Clinical Trial Stages, Drug Mechanism Classes, Short-term Launch Highlights, and Companies - ResearchAndMarkets.com

Retrieved on: 
Friday, June 14, 2019
Health, Clinical trials, Pharmaceutical, Health, Genodermatoses, Rare diseases, RTT, Epidermolysis bullosa, Clinical research, Design of experiments, Clinical trial, Scioderm, Epidermolysis bullosa simplex

The "Global Epidermolysis Bullosa Clinical Trial Pipeline Highlights, 2019" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Epidermolysis Bullosa Clinical Trial Pipeline Highlights, 2019" report has been added to ResearchAndMarkets.com's offering.
  • This report provides most up-to-date information on key pipeline products in the global Epidermolysis Bullosa market.
  • It covers emerging therapies for Epidermolysis Bullosa in active clinical development stages including early and late stage clinical trials.
  • The report provides Epidermolysis Bullosa pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.